Ravulizumab Subcutaneous (SC) Versus Ravulizumab Intravenous (IV) in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab - NCT03748823

---

ERÇALIŞKAN A., AR M. C.

2019 - 2023

• Başlama Tarihi: Şubat 2019
• Bitiş Tarihi: Ağustos 2023